Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEMO-103 Injection for MR Arthrography in Shoulder Joint Diseases
NCT07057037Phase 3Active, not recruiting
- Sponsor
- Inventera Pharmaceutical Co Ltd
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of INV-002 in shoulder arthritis, sponsored by Inventera Pharmaceutical Co Ltd. Started Sep 2025; status: active, not recruiting.
02
Drugs
INV-002
03
Conditions
shoulder arthritis
Beyond the preview
Go deeper on NCT07057037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057037.